JCB, Volume 8, Number 4, 2002 Editorial Vol.8 No. 4 (2002) A new season for biotechnology in Europe Andrea Rappagliosi Comments on the status of the biotechnology industry in Europe as of March 2002. Research system for life sciences in Europe; Changes in the European Union's (EU) policy Article Vol.8 No. 4 (2002) Practical experiences in starting up life science companies in the academic sector Paul Rodgers The authors discuss their experiences in starting up life science companies in the academic sector as a means of identifying the key issues and highlighting ways of addressing these Article Vol.8 No. 4 (2002) Pitfalls to avoid when starting a biotechnology company in the USA Virginia Kapner This paper presents an overview of some of the principal legal issues associated with establishing a biotechnology venture in the USA. We address the basic rules surrou Article Vol.8 No. 4 (2002) Forecasting new product revenues Lisa McIntyre This paper discusses real-life experiences in developing revenue forecasts for biopharmaceutical clients. The importance of forecasts based on emerging information about t Article Vol.8 No. 4 (2002) Employment and management trends in the biotechnolgy industry Cynthia Larbey This paper takes a look at the major influences on the biotechnology industry and how they are currently affecting employment and management trends. It takes a brief lo Article Vol.8 No. 4 (2002) Security issues for systems used for collecting, storing and interpreting human biological data David Harrison Over recent years there has been a substantial increase in the number of computerised systems used within the healthcare industry. The system's operation and the data pr Article Vol.8 No. 4 (2002) Strategies for attracting healthcare venture capital. Beth Silverstein Scientists or entrepreneurs in the area of biotechnology seeking to convert their discoveries into commercially viable products can find the effort daunting given that it combines th Article Vol.8 No. 4 (2002) Intellectual property: The driving force for growth and funding Judith E Schneider For most 'bio-entrepreneurs' the science is the easy part -- leveraging that science to create a viable business becomes the real challenge. This paper provides an over Article Vol.8 No. 4 (2002) Animal biotechnology: A study of opinions among stakeholder groups in the academic, pharmaceutical and agrifood sectors Sharon McNeil The commercialisation of animal biotechnology for use in human medical applications and as food will require the availability of accurate market information. As witnesse Article Vol.8 No. 4 (2002) Achieving venture returns through corporate spinouts Ashley Ledbetter As the biotechnology industry matures, the opportunity arises to establish companies by 'spinning out' undervalued but significant assets from larger biotechnology or pharmaceutical Legal and Regulatory Updates Vol.8 No. 4 (2002) Legal and regulatory update John Wilkinson   Legal and Regulatory Updates Vol.8 No. 4 (2002) EU Financial accounts reports David Citron  Â